Naurex, Inc.

Naurex, Inc.

Naurex, Inc.

Overview
Date Founded

2006

Headquarters

1801 MAPLE AVENUE SUITE 4300 EVANSTON IL 60201

Type of Company

Private

Employees (Worldwide)

11 - 50

Industries

Pharmaceuticals
Biotechnology

Company Description

Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL.

Contact Data
Trying to get in touch with decision makers at Naurex, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President, Chief Executive Officer & Director

President

Executive Officer

Paths to Naurex, Inc.
Potential Connections via
Relationship Science
You
Naurex, Inc.
Recent Transactions
Details Hidden

Allergan Plc purchases Naurex, Inc. from Latterell Venture Partners, Genesys Capital Partners, Inc., Adams Street Partners LLC, Takeda Ventures, Inc., Baxter Ventures

Details Hidden

Naurex, Inc. raised money in a private placement transaction

Details Hidden

Naurex, Inc. raised money in a private placement transaction

Transaction Advisors
Investment Advisor

Advised onAllergan Plc purchases Naurex, Inc. from Latterell Venture Partners, Genesys Capital Partners, Inc., Adams Street Partners LLC, Takeda Ventures, Inc., Baxter Ventures

Legal Advisor

Advised onAllergan Plc purchases Naurex, Inc. from Latterell Venture Partners, Genesys Capital Partners, Inc., Adams Street Partners LLC, Takeda Ventures, Inc., Baxter Ventures

Legal Advisor

Advised onAllergan Plc purchases Naurex, Inc. from Latterell Venture Partners, Genesys Capital Partners, Inc., Adams Street Partners LLC, Takeda Ventures, Inc., Baxter Ventures

Legal Advisor

Advised onAllergan Plc purchases Naurex, Inc. from Latterell Venture Partners, Genesys Capital Partners, Inc., Adams Street Partners LLC, Takeda Ventures, Inc., Baxter Ventures

Legal Advisor

Advised onAllergan Plc purchases Naurex, Inc. from Latterell Venture Partners, Genesys Capital Partners, Inc., Adams Street Partners LLC, Takeda Ventures, Inc., Baxter Ventures

Investors
Details Hidden

Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for patients worldwide through leading innovation in medicine. Takeda's ethical drugs are marketed in around 100 countries worldwide.

Details Hidden

PathoCapital LLC is a privately owned investment company that invests in healthcare companies. The company was founded by Wilbur H. Gantz in 2009 and is headquartered in Anaheim, CA.

Details Hidden

Baxter International Inc. (NYSE:BAX), through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2011 sales of $13.9 billion and has approximately 48,500 employees.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Naurex, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Naurex, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Naurex, Inc..